Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling
Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling
复制标题
肝脏 miR-378 靶向 p110α,并通过调节肝脏胰岛素信号传导来控制葡萄糖和脂质稳态。
DOI:
10.1038/ncomms6684
复制
发表时间:
2014-12-01
影响因子:
16.6
通讯作者:
Ying, Hao
中科院分区:
文献类型:
--
作者:
Liu, Wei;Cao, Hongchao;Ying, Hao
Understanding the regulation of insulin signalling in tissues provides insights into carbohydrate and lipid metabolism in physiology and disease. Here we show that hepatic miR-378/378* expression changes in response to fasting and refeeding in mice. Mice overexpressing hepatic miR-378/378* exhibit pure hepatic insulin resistance. miR-378 inhibits hepatic insulin signalling through targeting p110 alpha, a subunit of PI3K and hence a critical component of insulin signalling. Knockdown of hepatic p110 alpha mimics the effect of miR-378, while restoration of p110 alpha expression abolishes the action of miR-378 on insulin signalling as well as its systemic effects on glucose and lipid homeostasis. miR-378/378* knockout mice display hypoglycemia and increased hepatic triglyceride level with enhanced insulin sensitivity. Inhibition of hepatic p110 alpha in miR-378/378* knockout mice corrects the abnormal glucose tolerance. Finally, we show that overexpression of hepatic miR-378/378* ameliorates hepatic steatosis in ob/ob mice without exacerbating hyperglycemia. Our findings establish fasting-responsive miR-378 as a critical regulator of hepatic insulin signalling.